Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$933 Hold
9
﹤0.01% 447
2025
Q4
$907 Hold
9
﹤0.01% 410
2025
Q3
$1.11K Hold
9
﹤0.01% 375
2025
Q2
$1.08K Hold
9
﹤0.01% 376
2025
Q1
$1.32K Hold
9
﹤0.01% 269
2024
Q4
$1.46K Hold
9
﹤0.01% 252
2024
Q3
$1.47K Sell
9
-1
-10% -$148 ﹤0.01% 241
2024
Q2
$1.36K Buy
+10
New +$1.39K ﹤0.01% 211

Other funds holding CLX

Swan Capital's CLX Position: Q1 2026 in Review

Swan Capital held its Clorox (CLX) position steady in Q1 2026 at 9 shares worth $933. The position accounts for ﹤0.01% of the portfolio, ranked #447.

Swan Capital first reported a position in CLX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.47K in Q3 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Swan Capital held 9 shares of Clorox worth $933 as of Q1 2026.
  • Swan Capital left its Clorox share count unchanged in Q1 2026.
  • Clorox made up ﹤0.01% of Swan Capital's portfolio in Q1 2026, its #447 holding.
  • Swan Capital first reported a position in Clorox in Q2 2024 and has held it in 8 quarters since.
  • Swan Capital's Clorox position peaked at $1.47K in Q3 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.